Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesReceivables - Net
Ratios

Regen BioPharma (RGBP) Receivables - Other (2016 - 2018)

Regen BioPharma (RGBP) has disclosed Receivables - Other for 5 consecutive years, with $5120.0 as the latest value for Q4 2018.

  • On a quarterly basis, Receivables - Other fell 49.3% to $5120.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $5120.0, a 49.3% decrease, with the full-year FY2018 number at $20000.0, up 350.86% from a year prior.
  • Receivables - Other was $5120.0 for Q4 2018 at Regen BioPharma, down from $7672.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $102852.0 in Q2 2017 to a low of $14.0 in Q2 2014.
  • A 5-year average of $12692.2 and a median of $2878.0 in 2016 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: skyrocketed 7621.43% in 2015, then tumbled 73.91% in 2017.
  • Regen BioPharma's Receivables - Other stood at $493.0 in 2014, then surged by 240.97% to $1681.0 in 2015, then surged by 71.21% to $2878.0 in 2016, then surged by 250.9% to $10099.0 in 2017, then tumbled by 49.3% to $5120.0 in 2018.
  • Per Business Quant, the three most recent readings for RGBP's Receivables - Other are $5120.0 (Q4 2018), $7672.0 (Q3 2018), and $58000.0 (Q2 2018).